TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11341138

Group type: EXPERIMENTAL
Intervention: Intervention program targeting physicians with recommendations to reduce PIPs
Number of subjects: 266

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Intervention with case conferences
Number of subjects: 266
Study: 8995746

Group type: EXPERIMENTAL
Intervention: CU (cuprophane) membrane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PS (polysulfone) membrane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PAN (polyacrylonitrile) membrane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CU dialyzer (outlet)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CU (heparinized uremic blood samples)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PS (heparinized uremic blood samples)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PAN (heparinized uremic blood samples)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (heparinized uremic blood samples)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CU, PS, PAN membranes
Number of subjects: 10
Study: 8302306

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 3734451

Group type: EXPERIMENTAL
Intervention: 80 mmol/day of KCl (Slow‐K, Ciba Geigy)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 44
Study: 29750366

Group type: EXPERIMENTAL
Intervention: Choline supplementation (2 g daily oral dose)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 27358385

Group type: EXPERIMENTAL
Intervention: Palonosetron (0.75 mg)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Granisetron (1 mg)
Number of subjects: 842
Study: 25065693

Group type: EXPERIMENTAL
Intervention: 3% Cherry Blossom Extract (CBE)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21739132

Group type: EXPERIMENTAL
Intervention: Saanen parent stock (SAPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saanen F1 (SAF1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anglo-Nubian F1 (ANF1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anglo-Nubian parent stock (ANSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anglo-Nubian parent stock (ANPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saanen F1
Number of subjects: 0

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 0
Study: 18976753

Group type: EXPERIMENTAL
Intervention: Contraceptive patch
Number of subjects: 500

Group type: COMPARATOR
Intervention: Contraceptive ring
Number of subjects: 500
Study: 18574140

Group type: EXPERIMENTAL
Intervention: Prospective CT angiography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Retrospective CT angiography
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study: 16095058

Group type: EXPERIMENTAL
Intervention: IRCR
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: CR
Number of subjects: 19

Group type: COMPARATOR
Intervention: Enamel
Number of subjects: 19
Study: 11803003

Group type: EXPERIMENTAL
Intervention: DTPa/Hib
Number of subjects: 200

Group type: COMPARATOR
Intervention: DTPw/Hib
Number of subjects: 200
Study: 10737366

Group type: EXPERIMENTAL
Intervention: Preoperative pentoxifiline (PTFL) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no PTFL)
Number of subjects: 0
Study: 9189781

Group type: EXPERIMENTAL
Intervention: Flavored, 6% sucrose drink containing 25 mmol/L NaCl (LNa(+)‐R)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flavored, 6% sucrose drink containing 50 mmol/L NaCl (HNa(+)‐R)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Flavored/artificially sweetened water (H2O‐R)
Number of subjects: 6
Study: 1332356

Group type: EXPERIMENTAL
Intervention: mepivacaine‐adrenaline (pH = 6.1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: mepivacaine‐adrenaline (pH = 7.5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: bupivacaine‐adrenaline (pH = 6.1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: bupivacaine‐adrenaline (pH = 7.4)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: adrenaline (pH = 6.1)
Number of subjects: 40
Study: 3872836

Group type: EXPERIMENTAL
Intervention: Carprofen (300 mg/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 29150850

Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg/d)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Prasugrel (10 mg/d)
Number of subjects: 140
Study: 27362350

Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment
Number of subjects: 50
Study: 25436771

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) at 1.5 ATA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (HBO2) at 2.0 ATA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham-control
Number of subjects: 60
Study: 21965226

Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily for 12 weeks
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 20097780

Group type: EXPERIMENTAL
Intervention: Collaborative depression care (problem-solving therapy and/or antidepressant medication, telephone follow-up, systems navigation assistance)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Enhanced usual care (standard clinic care, depression educational pamphlets, community resource list)
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Collaborative depression care
Number of subjects: 387
Study: 18339831

Group type: EXPERIMENTAL
Intervention: Expert Patients Programme (EPP) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 0
Study: 15758802

Group type: EXPERIMENTAL
Intervention: Betamethasone valerate 0.06%
Number of subjects: 70

Group type: COMPARATOR
Intervention: Clobetasone butyrate 0.05%
Number of subjects: 70
Study: 12576246

Group type: EXPERIMENTAL
Intervention: 5 mg of mifepristone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mg of mifepristone
Number of subjects: 40
Study: 10382880

Group type: EXPERIMENTAL
Intervention: Oral administration of 400 mg moxifloxacin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous administration of 400 mg moxifloxacin
Number of subjects: 12
Study: 8724874

Group type: EXPERIMENTAL
Intervention: Naso‐esophageal probe
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: pH of the esophageal content
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Volume of esophageal contents
Number of subjects: 41
Study: 31918612

Group type: EXPERIMENTAL
Intervention: Relaxation microbreak
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Mastery microbreak
Number of subjects: 199

Group type: COMPARATOR
Intervention: No break
Number of subjects: 199
Study: 30232625

Group type: EXPERIMENTAL
Intervention: Biodentine™
Number of subjects: 53

Group type: COMPARATOR
Intervention: Fuji IX™ (control)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Biodentine™ and Fuji IX™
Number of subjects: 53
Study: 28282743

Group type: EXPERIMENTAL
Intervention: Power (POW); 3 sets × 6 repetitions at 45%1RM × 3 min inter‐set rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Strength (ST); 3 sets × 3 repetitions at 90%1RM × 3 min inter‐set rest
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hypertrophy (HYP); 3 sets × 10 repetitions at 70%1RM × 1 min inter‐set rest
Number of subjects: 12
Study: 27154301

Group type: EXPERIMENTAL
Intervention: Group dynamics-based-high presence
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Group dynamics-based-low presence
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Standard social support
Number of subjects: 135

Group type: COMPARATOR
Intervention: Individual control
Number of subjects: 135
Study: 24719128

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 54

Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Plasmalyte
Number of subjects: 54
Study: 21816681

Group type: EXPERIMENTAL
Intervention: 2-year multilevel intervention with monthly on-site consultation from expert nurses
Number of subjects: 58

Group type: COMPARATOR
Intervention: Attention control with monthly information about aging and physical assessment of elders
Number of subjects: 58
Study: 17919894

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15-30 mg/day) added to metformin or sulphonylurea
Number of subjects: 250

Group type: COMPARATOR
Intervention: Fixed-dose combination of metformin (400mg) and glibenclamide (2.5 mg)
Number of subjects: 250
Study: 15916993

Group type: EXPERIMENTAL
Intervention: BCT + CRT magazines
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: BCT magazines
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: CRT magazines
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 1227
Study: 12809818

Group type: EXPERIMENTAL
Intervention: Surgical (Nissen fundoplication)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Medical (ranitidine 150 mg t.i.d.)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (antacids as needed)
Number of subjects: 62
Study: 10807093

Group type: EXPERIMENTAL
Intervention: Crutches set to conventional guidelines
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Crutches set 2.5 cm longer than conventional guidelines
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Crutches set 2.5 cm shorter than conventional guidelines
Number of subjects: 20
Study: 9387512

Group type: EXPERIMENTAL
Intervention: Ritodrine
Number of subjects: 126

Group type: COMPARATOR
Intervention: Magnesium sulfate
Number of subjects: 126
Study: 1484022

Group type: EXPERIMENTAL
Intervention: 1 gm sucralfate four times a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: 150 mg ranitidine tablet twice daily
Number of subjects: 40
Study: 3926614

Group type: EXPERIMENTAL
Intervention: 20 mg isosorbide dinitrate in sustained-release form (sustained-release ISDN)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 20 mg isosorbide 5-mononitrate (IS 5-MN)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 2.5 mg buccal nitroglycerin in sustained-release form (NTGB)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 6.5 mg oral nitroglycerin in sustained-release form (NTGO)
Number of subjects: 32
Study: 29636305

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) at 30% of maximal inspiratory pressure (MIP) for 6 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham therapy (5% of MIP) for 6 weeks
Number of subjects: 25
Study: 27821107

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture with distal-proximal point association (Neiguan (PC6) and Zhongwan (CV12))
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture with distal-proximal point association (Zusanli (ST36) and CV12)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture with local distribution point association (Shangwan (CV13) and CV12)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Standard antiemetic only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture treatments
Number of subjects: 240
Study: 25070320

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1000 IU/d)
Number of subjects: 1787

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1787
Study: 22480187

Group type: EXPERIMENTAL
Intervention: Moderate insulin therapy (MIT) with glucose target 120 to 140 mg/dl
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT) with glucose target 180 to 200 mg/dl
Number of subjects: 112
Study: 20678878

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day plus ASA 75 to 100 mg/day
Number of subjects: 851

Group type: COMPARATOR
Intervention: Placebo plus ASA 75 to 100 mg/day
Number of subjects: 851
Study: 17511748

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15663583

Group type: EXPERIMENTAL
Intervention: Bishop score
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Cervical length
Number of subjects: 266
Study: 12534429

Group type: EXPERIMENTAL
Intervention: Heavier social users of alcohol (n=100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lighter social users of alcohol and non‐users (n=100)
Number of subjects: 200
Study: 10370642

Group type: EXPERIMENTAL
Intervention: Molsidomine
Number of subjects: 8

Group type: COMPARATOR
Intervention: NOx levels
Number of subjects: 8
Study: 8777101

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 micrograms kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diltiazem 0.2 mg kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Verapamil 0.1 mg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 60
Study: 2051002

Group type: EXPERIMENTAL
Intervention: Quinidine sulfate 400 mg per day
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 6881428

Group type: EXPERIMENTAL
Intervention: Oral rehydration solutions (ORS) containing 90 mmol/liter of sodium
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Oral rehydration solutions (ORS) containing 50 mmol/liter of sodium
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard outpatient management (Control)
Number of subjects: 93
Study: 30075736

Group type: EXPERIMENTAL
Intervention: Intensity modulated radiation therapy (IMRT)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: RapidArc
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Positron emission tomography/computed tomography (PET/CT) with F‐18 fluorodeoxyglucose (FDG)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Comet assay‐guided IMRT
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Comet assay‐guided RapidArc
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cisplatin 30 mg/m2 weekly for five courses
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Two to four cycles of TP (Taxol 135 mg/m2, D1, and DDP 75 mg/m2, D1‐3) sequential chemotherapy
Number of subjects: 300
Study: 26740259

Group type: EXPERIMENTAL
Intervention: Pazopanib
Number of subjects: 664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study: 24904748

Group type: EXPERIMENTAL
Intervention: Exercise therapy combined with spinal manipulation
Number of subjects: 184

Group type: COMPARATOR
Intervention: Exercise therapy alone
Number of subjects: 184
Study: 22402803

Group type: EXPERIMENTAL
Intervention: Lower blood pressure goal (mean arterial pressure ≤92 mmHg)
Number of subjects: 949

Group type: COMPARATOR
Intervention: Not applicable (remaining patients)
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Trial phase (125I-iothalamate-measured GFR)
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Low levels of proteinuria at baseline
Number of subjects: 949
Study: 20384499

Group type: EXPERIMENTAL
Intervention: Symptom assessment using the Memorial Symptom Assessment Scale-Short Form (MSAS-SF)
Number of subjects: 212
Study: 18480682

Group type: EXPERIMENTAL
Intervention: Peony‐Glycyrrhiza Decoction (PGD) 45 g/d
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bromocriptine (BMT) 5 mg/d
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Peony‐Glycyrrhiza Decoction (PGD)
Number of subjects: 20
Study: 16316784

Group type: EXPERIMENTAL
Intervention: Pulse steroid therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low dose steroid treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: No steroid treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD14-independent LPS-binding and activation
Number of subjects: 0
Study: 14627912

Group type: EXPERIMENTAL
Intervention: Extended daclizumab induction, tacrolimus, and mycophenolate mofetil (MMF)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Steroid-free protocol
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Steroid-free protocol with modified dosing
Number of subjects: 57

Group type: COMPARATOR
Intervention: Historical matched steroid-based control
Number of subjects: 57
Study: 10998732

Group type: EXPERIMENTAL
Intervention: Bisphosphonates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pharmacologic treatment, radiotherapy, and radioisotopes
Number of subjects: 0
Study: 8795448

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (30 p.p.m. for 15 min)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (80 p.p.m. for 15 min)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prolonged inhalation of nitric oxide (30 p.p.m. for 55 min)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Aspirin (640 mg orally)
Number of subjects: 19
Study: 1538279

Group type: EXPERIMENTAL
Intervention: Educational and family support services and pediatric follow‐up during the first 3 years of life
Number of subjects: 985

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 985
Study: 6142254

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination of washed motile fraction of spermatozoa
Number of subjects: 35

Group type: COMPARATOR
Intervention: Natural intercourse timed by symptothermal methods
Number of subjects: 35

Group type: COMPARATOR
Intervention: LH-timed intercourse
Number of subjects: 35
Study: 30554365

Group type: COMPARATOR
Intervention: Glycerine iodine 10% daily for 7 days
Number of subjects: 37

Group type: COMPARATOR
Intervention: Eniloconazole 10% emulsified concentrate four times with 2 days interval
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Neem seeds extract (20% cream) daily for 10 days
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sumaq extract (5% cream) daily for 10 days
Number of subjects: 37
Study: 31299999

Group type: EXPERIMENTAL
Intervention: Quadriceps functional electrical stimulation (FES) synchronized with walking for 10 minutes, three days a week, in addition to standard rehabilitation.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Quadriceps neuromuscular electrical stimulation (NMES) (duty cycle of 10s on/10s off) for 10 minutes, three days a week, in addition to standard rehabilitation.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Quadriceps functional electrical stimulation (FES) synchronized with walking.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Quadriceps neuromuscular electrical stimulation (NMES).
Number of subjects: 23
Study: 28301614

Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion (halobetasol propionate 0.01% and tazarotene 0.045%)
Number of subjects: 212

Group type: COMPARATOR
Intervention: HP lotion (halobetasol propionate 0.01%)
Number of subjects: 212

Group type: COMPARATOR
Intervention: TAZ (tazarotene 0.045%)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: HP/TAZ lotion
Number of subjects: 212
Study: 25297660

Group type: EXPERIMENTAL
Intervention: Patient-led titration
Number of subjects: 552

Group type: COMPARATOR
Intervention: Physician-led titration
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 552
Study: 23747986

Group type: EXPERIMENTAL
Intervention: Video-assisted informed consent format
Number of subjects: 61

Group type: COMPARATOR
Intervention: Paper version of informed consent
Number of subjects: 61
Study: 20817209

Group type: EXPERIMENTAL
Intervention: Lund technique (n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Carbon dioxide insufflation technique (n = 10)
Number of subjects: 20
Study: 18654783

Group type: EXPERIMENTAL
Intervention: Single dose of Gd-DTPA (approximately 0.1 mmol/kg bw)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Double dose of Gd-DTPA
Number of subjects: 10
Study: 17032158

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy plus treatment as usual (CBT plus TAU)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 106
Study: 12937052

Group type: EXPERIMENTAL
Intervention: Dexamethasone administration (1993-1994 cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone administration (2001 cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic lung disease in survivors (1993-1994 cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chronic lung disease in survivors (2001 cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mortality (1993-1994 cohort)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mortality (2001 cohort)
Number of subjects: 0
Study: 10664926

Group type: EXPERIMENTAL
Intervention: Timolol ophthalmic solution (0.5%, 0.05 mL to each eye) with cimetidine (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Timolol ophthalmic solution (0.5%, 0.05 mL to each eye)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cimetidine (400 mg)
Number of subjects: 12
Study: 9287258

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 50 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified-release dipyridamole 400 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ASA 25 mg b.d. and dipyridamole 200 mg b.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8345978

Group type: EXPERIMENTAL
Intervention: Oral amoxicillin/potassium clavulanate
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Intramuscular ceftriaxone
Number of subjects: 519

Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 519
Study: 3013567

Group type: EXPERIMENTAL
Intervention: Parenteral sulbactam/ampicillin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clindamycin/gentamicin
Number of subjects: 60
Study: 31594205

Group type: COMPARATOR
Intervention: Intra-articular distension followed by physical therapy (Group A)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Intra-articular distension preceded by physical therapy (Group B)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Physical therapy alone (Group C)
Number of subjects: 122
Study: 28326609

Group type: EXPERIMENTAL
Intervention: Specialized 1-hr training program in suicide prevention
Number of subjects: 162

Group type: COMPARATOR
Intervention: Stress and time management skills training program
Number of subjects: 162
Study: 27181179

Group type: EXPERIMENTAL
Intervention: EPO (40,000 IU/ml)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Saline (0.9% NaCl)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: EPO
Number of subjects: 83